Locations
Concord, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2020
Comanche Biopharma is a biopharmaceutical company focused on developing an investigational siRNA medicine for preterm preeclampsia. The company aims to provide safe and effective therapies for life-threatening complications of pregnancy, ensuring that these solutions are evidence-based and affordable. Founded by a diverse team of experts, Comanche is committed to addressing the historical neglect of maternal health in drug development, striving to create accessible treatments for all women and their babies. With a mission to make every pregnancy safer, Comanche is positioned to lead in the biopharmaceutical space, particularly in addressing preeclampsia, a significant health issue affecting many expectant mothers.
Something looks off?